New insider activity at Bio-Rad Laboratories ( (BIO) ) has taken place on March 19, 2025.
Michael Crowley, the Executive Vice President of Global Commercial Operations at Bio-Rad Laboratories, has recently sold 3,000 shares of the company’s stock. This transaction was valued at $741,180, reflecting a significant financial move within the organization.
More about Bio-Rad Laboratories
YTD Price Performance: -21.20%
Average Trading Volume: 251,253
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $7.14B